Hong Kong F&B: Stock Screening As Social-Distancing Curbs Ease
I'm inclined to pursue pure-restaurant outlet/venue companies, as oppsed to those with hotel operations, the latter of which remains highly...
393 Views
Nongfu Spring IPO: Trading Debut
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
465 Views
Nongfu Spring IPO: Valuation Insights
Nongfu Spring (9633 HK) is a leader in the packaged drinking water and beverage business in China. Nongfu had the leading market share in the...
864 Views
No more insights